The European Journal of Health Economics

2002 - 2025

Current editor(s): J.-M.G.v.d. Schulenburg

From:
Springer
Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ)
Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

Access Statistics for this journal.
Is something missing from the series or not right? See the RePEc data check for the archive and series.

Volume 23, issue 9, 2022

Reassessing the impact of health expenditure on income growth in the face of the global sanitary crisis: the case of developing countries pp. 1415-1436

Brahim Gaies

Should administrative costs in health insurance be included in the risk-equalization? An analysis of five countries pp. 1437-1453

Rudy Douven, Lukas Kauer, Sylvia Demme, Francesco Paolucci, Wynand Ven, Jürgen Wasem and Xiaoxi Zhao

Determinants of willingness to pay for health services: a systematic review of contingent valuation studies pp. 1455-1482

Caroline Steigenberger, Magdalena Flatscher-Thoeni, Uwe Siebert and Andrea Leiter

Population preferences for non-pharmaceutical interventions to control the SARS-CoV-2 pandemic: trade-offs among public health, individual rights, and economics pp. 1483-1496

Axel C. Mühlbacher, Andrew Sadler and Yvonne Jordan

Pharmaceutical pricing dynamics in an internal reference pricing system: evidence from changing drugs’ reimbursements pp. 1497-1518

Eduardo Costa and Carolina Santos

Equity in healthcare utilization in Canada’s publicly funded health system: 2000–2014 pp. 1519-1533

Laura Hirello, Mohammad Habibullah Pulok and Mohammad Hajizadeh

The effect of informal caregiving on medication: evidence from administrative data pp. 1535-1545

Magdalena Stroka-Wetsch

The attractiveness of jobs in the German care sector: results of a factorial survey pp. 1547-1562

Martin Kroczek and Jochen Späth

Are costs derived from diagnosis-related groups suitable for use in economic evaluations? A comparison across nine European countries in the European Healthcare and Social Cost Database pp. 1563-1575

Zuzana Špacírová, David Epstein and Jaime Espín

A comprehensive review of official discount rates in guidelines of health economic evaluations over time: the trends and roots pp. 1577-1590

Elahe Khorasani, Majid Davari, Abbas Kebriaeezadeh, Farshad Fatemi, Ali Akbari Sari and Vida Varahrami

The impact of cost-sharing on prescription drug demand: evidence from a double-difference regression kink design pp. 1591-1599

Simona Gamba, Niklas Jakobsson and Mikael Svensson

Looking into the black box of “Medical Innovation”: rising health expenditures by illness type pp. 1601-1612

Friedrich Breyer, Normann Lorenz, Gerald Pruckner and Thomas Schober

Correction to: Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology pp. 1613-1615

Stefan A. Lipman, Liying Zhang, Koonal K. Shah and Arthur Attema

Volume 23, issue 8, 2022

Breaking the rules: decision-making under absolute resource constraints pp. 1259-1261

Peter Lindgren

COVID-19 health policy evaluation: integrating health and economic perspectives with a data envelopment analysis approach pp. 1263-1285

Matthias Klumpp, Dominic Loske and Silvio Bicciato

Value drivers of development stage biopharma companies pp. 1287-1296

Daniel Tobias Michaeli, Hasan Basri Yagmur, Timur Achmadeev and Thomas Michaeli

Do we care about high-cost patients? Estimating the savings on health spending by integrated care pp. 1297-1308

Karen Geurts, Marc Bruijnzeels and Erik Schokkaert

Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations pp. 1309-1317

Don Husereau, Michael Drummond, Federico Augustovski, Esther Bekker-Grob, Andrew H. Briggs, Chris Carswell, Lisa Caulley, Nathorn Chaiyakunapruk, Dan Greenberg, Elizabeth Loder, Josephine Mauskopf, C. Daniel Mullins, Stavros Petrou, Raoh-Fang Pwu and Sophie Staniszewska

Does the abolition of copayment increase ambulatory care utilization?: a quasi-experimental study in Germany pp. 1319-1328

Mingming Xu and Benjamin Bittschi

The impact of ambulatory care spending, continuity and processes of care on ambulatory care sensitive hospitalizations pp. 1329-1340

Wiebke Schuettig and Leonie Sundmacher

Validation of the PAM-13 instrument in the Hungarian general population 40 years old and above pp. 1341-1355

Zsombor Zrubka, Péter Vékás, Péter Németh, Ágota Dobos, Ottó Hajdu, Levente Kovács, László Gulácsi, Judith Hibbard and Márta Péntek

Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data pp. 1357-1369

Aileen R. Neilson, Gareth T. Jones, Gary J. Macfarlane, Ejaz MI Pathan and Paul McNamee

Cost-minimisation analysis of oritavancin for the treatment of acute bacterial skin and skin structure infections from a United Kingdom perspective pp. 1371-1381

Daniela Zinzi, Ioanna Vlachaki, Edel Falla, Theo Mantopoulos and Dilip Nathwani

Psychometric performance of proxy-reported EQ-5D youth version 5-level (EQ-5D-Y-5L) in comparison with three-level (EQ-5D-Y-3L) in children and adolescents with scoliosis pp. 1383-1395

Jiaer Lin, Carlos King Ho Wong, Jason Pui Yin Cheung, Prudence Wing Hang Cheung and Nan Luo

Does voluntary health insurance improve health and longevity? Evidence from European OECD countries pp. 1397-1411

Simona Laura Dragos, Codruta Mare, Cristian Mihai Dragos, Gabriela Mihaela Muresan and Alexandra-Anca Purcel

Correction: Lifetime direct healthcare costs of treating colorectal cancer: a systematic review pp. 1413-1413

Nazim Bhimani, Geoffrey Y. M. Wong, Charles Molloy, Mbathio Dieng, Patrick J. Kelly and Thomas J. Hugh

Volume 23, issue 7, 2022

Challenges for health systems seeking to embrace virtual health care for population health pp. 1079-1083

Panos Kanavos, Michelle Vogelsang, Madeleine Haig and Vasiliki Kolovou

Defining minimum volume thresholds to increase quality of care: a new patient-oriented approach using mixed integer programming pp. 1085-1104

Justus F. A. Vogel, Max Barkhausen, Christoph M. Pross and Alexander Geissler

Reliability and validity of using EQ-5D-5L among healthy and adolescents with major mental health disorders in Ethiopia pp. 1105-1119

Abraham G. Welie, Elly Stolk, Clara Mukuria, Yared Belete Belay, Murray D. Krahn, Beate Sander and Gebremedhin Beedemariam Gebretekle

Ageing and health care expenditures: the importance of age per se, steepening of the individual-level expenditure curve, and the role of morbidity pp. 1121-1149

Anna Kollerup, Jakob Kjellberg and Rikke Ibsen

Modelling decay in effectiveness for evaluation of behaviour change interventions: a tutorial for public health economists pp. 1151-1157

Paolo Candio, Koen B. Pouwels, David Meads, Andrew J. Hill, Laura Bojke and Claire Williams

Cost-effectiveness of 12 months of capecitabine as adjuvant chemotherapy for stage III colon cancer: preplanned cost-effectiveness analysis of the JFMC37-0801 study pp. 1159-1171

Hidetoshi Shibahara, Takeru Shiroiwa, Megumi Ishiguro, Masato Nakamura, Junichi Hasegawa, Shigeki Yamaguchi, Yuriko Masuda, Junichi Sakamoto, Naohiro Tomita and Takashi Fukuda

Probabilistic microsimulation to examine the cost-effectiveness of hospital admission screening strategies for carbapenemase-producing enterobacteriaceae (CPE) in the United Kingdom pp. 1173-1185

Sarkis Manoukian, Sally Stewart, Stephanie J. Dancer, Helen Mason, Nicholas Graves, Chris Robertson, Alistair Leonard, Sharon Kennedy, Kim Kavanagh, Benjamin Parcell and Jacqui Reilly

Catastrophic household expenditure associated with out-of-pocket payments for dental healthcare in Spain pp. 1187-1201

Samuel López-López, Raúl Pozo-Rubio, Marta Ortega-Ortega and Francisco Escribano-Sotos

Supply-side solutions targeting demand-side characteristics: causal effects of a chronic disease management program on adherence and health outcomes pp. 1203-1220

Luke Connelly, Gianluca Fiorentini and Marica Iommi

Cost-effectiveness of screening smokers and ex-smokers for lung cancer in the Netherlands in different age groups pp. 1221-1227

Mohamed N. M. T. Al Khayat, Job F. H. Eijsink, Maarten J. Postma, Ewoudt M. W. Garde and Marinus Hulst

Can competition improve hospital quality of care? A difference-in-differences approach to evaluate the effect of increasing quality transparency on hospital quality pp. 1229-1242

Christoph Strumann, Alexander Geissler, Reinhard Busse and Christoph Pross

Measuring the acceptability of EQ-5D-3L health states for different ages: a new adaptive survey methodology pp. 1243-1255

Zoltan Hermann, Márta Péntek, László Gulácsi, Irén Anna Kopcsóné Németh and Zsombor Zrubka

Correction to: Geographic distribution of physicians in Portugal pp. 1257-1257

Isabel Correia and Paula Veiga

Volume 23, issue 6, 2022

European union regulation of health technology assessment: what is required for it to succeed? pp. 913-915

Michael Drummond, Rosanna Tarricone and Aleksandra Torbica

Comparison of ARIMA, ETS, NNAR, TBATS and hybrid models to forecast the second wave of COVID-19 hospitalizations in Italy pp. 917-940

Gaetano Perone

Resource utilization and disaggregated cost analysis of bariatric surgery in the Australian public healthcare system pp. 941-952

Qing Xia, Julie Campbell, Hasnat Ahmad, Barbara Graaff, Lei Si, Petr Otahal, Kevin Ratcliffe, Julie Turtle, John Marrone, Mohammed Huque, Barry Hagan, Matthew Green and Andrew J. Palmer

Does compulsory schooling affect health? Evidence from ambulatory claims data pp. 953-968

Tatjana Begerow and Hendrik Jürges

Optimising the impact of COVID-19 vaccination on mortality and hospitalisations using an individual additive risk measuring approach based on a risk adjustment scheme pp. 969-978

Danny Wende, Dagmar Hertle, Claudia Schulte, Pedro Ballesteros and Uwe Repschläger

Costing methodologies in European economic evaluation guidelines: commonalities and divergences pp. 979-991

Leticia García-Mochón, Zuzana Špacírová and Jaime Espín

The impact on quality of life of diet restrictions and disease symptoms associated with phenylketonuria: a time trade-off and discrete choice experiment study pp. 993-1005

Sara Olofsson, Katarina Gralén, Christina Hoxer, Paul Okhuoya and Ulf Persson

The remarkably frequent use of EQ-5D in non-economic research pp. 1007-1014

Aimin Wang, Kim Rand, Zhihao Yang, Richard Brooks and Jan Busschbach

Income level and antibiotic misuse: a systematic review and dose–response meta-analysis pp. 1015-1035

Narmeen Mallah, Nicola Orsini, Adolfo Figueiras and Bahi Takkouche

Willingness-to-pay for cancer treatment and outcome: a systematic review pp. 1037-1057

Alene Sze Jing Yong, Yi Heng Lim, Mark Wing Loong Cheong, Ednin Hamzah and Siew Li Teoh

Value appropriation in hepatitis C pp. 1059-1070

Peter Lindgren, Sofia Löfvendahl, Gunnar Brådvik, Ola Weiland and Bengt Jönsson

Decision thresholds with genetic testing pp. 1071-1078

Stefan Felder

Volume 23, issue 5, 2022

Seeking efficiency gains outside drugs and diagnostics pp. 759-761

Reyes Lorente and Fernando Antonanzas

The cost-effectiveness of unilateral cochlear implants in UK adults pp. 763-779

Henry Cutler, Mutsa Gumbie, Emma Olin, Bonny Parkinson, Ross Bowman, Hafsa Quadri and Timothy Mann

What drives variations in public health and social services expenditures? the association between political fragmentation and local expenditure patterns pp. 781-789

Yonsu Kim and Jae Hong Kim

Adoption of large-scale medical equipment: the impact of competition in the German inpatient sector pp. 791-805

Marie Dreger, Hauke Langhoff and Cornelia Henschke

Cost–utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland pp. 807-821

Claudine Bommer, Judith Lupatsch, Nicole Bürki and Matthias Schwenkglenks

Characteristics and health care costs in patients with a diagnostic imaging for low back pain in Switzerland pp. 823-835

Stefania Di Gangi, Christophe Bagnoud, Giuseppe Pichierri, Thomas Rosemann and Andreas Plate

Cost-effectiveness and budget impact of venetoclax in combination with rituximab in relapsed/refractory chronic lymphocytic leukemia in Switzerland pp. 837-846

Michaela Barbier, Nicholas Durno, Craig Bennison, Mathias Örtli, Christian Knapp and Matthias Schwenkglenks

The effects of patient cost-sharing on health expenditure and health among older people: Heterogeneity across income groups pp. 847-861

Hirotaka Kato, Rei Goto, Taishi Tsuji and Katsunori Kondo

Towards compatibility of EUnetHTA JCA methodology and German HTA: a systematic comparison and recommendations from an industry perspective pp. 863-878

Agnes Kisser, Joschua Knieriemen, Annette Fasan, Karolin Eberle, Sara Hogger, Sebastian Werner, Tina Taube and Andrej Rasch

One last effort. Are high out-of-pocket payments at the end of life a fatality? pp. 879-891

Rosalind Bell-Aldeghi, Nicolas Sirven, Morgane Guern and Christine Sevilla-Dedieu

Work ethics, stay-at-home measures and COVID-19 diffusion pp. 893-901

Vincenzo Alfano

Examining the density in out-of-pocket spending share in the estimation of catastrophic health expenditures pp. 903-912

Abdulrahman Jbaily, Annie Haakenstad, Mizan Kiros, Carlos Riumallo-Herl and Stéphane Verguet

Volume 23, issue 4, 2022

Microeconomics of intertemporal choice in zero-space during Covid-19: a behavioral economics perspective pp. 559-563

Javier Cifuentes-Faura and Renaud Francesco

Short- and medium-term cost effects of non-indicated thyroid diagnostics: empirical evidence from German claims data pp. 565-595

Lucas Hafner, Valeria Biermann, Susann Hueber, Ewan Donnachie, Thomas Kühlein, Harald Tauchmann and Johanna Tomandl

A dynamic Markov model to assess the cost-effectiveness of the Kidney Team at Home intervention in The Netherlands pp. 597-606

Steef Redeker, Sohal Ismail, Hester V. Eeren, Emma K. Massey, Willem Weimar, Mark Oppe and Jan Busschbach

Estimation of the cost-effective threshold of a quality-adjusted life year in China based on the value of statistical life pp. 607-615

Dan Cai, Si Shi, Shan Jiang, Lei Si, Jing Wu and Yawen Jiang

Communities and testing for COVID-19 pp. 617-625

Steven Stillman and Mirco Tonin

Infections, accidents and nursing overtime in a neonatal intensive care unit pp. 627-643

Marc Beltempo, Georges Bresson, Jean-Michel Étienne and Guy Lacroix

Consideration of quality of life in the health technology assessments of rare disease treatments pp. 645-669

Elena Nicod, Michela Meregaglia, Amanda Whittal, Sheela Upadhyaya, Karen Facey and Michael Drummond

The residential healthcare for the elderly in Italy: some considerations for post-COVID-19 policies pp. 671-685

Alessandra Cepparulo and Luisa Giuriato

Is stronger religious faith associated with a greater willingness to take the COVID-19 vaccine? Evidence from Israel and Japan pp. 687-703

Eyal Lahav, Shosh Shahrabani, Mosi Rosenboim and Yoshiro Tsutsui

The impact of decentralisation on the performance of health care systems: a non-linear relationship pp. 705-715

Sean Dougherty, Luca Lorenzoni, Alberto Marino and Fabrice Murtin

Using Australian panel data to account for unobserved factors in measuring inequities for different channels of healthcare utilization pp. 717-728

Jonas Fooken and Varinder Jeet

The COVID-19 crisis and telework: a research survey on experiences, expectations and hopes pp. 729-753

Eline Moens, Louis Lippens, Philippe Sterkens, Johannes Weytjens and Stijn Baert

Demonstrating the value of cancer biomarkers at the population level pp. 755-756

Afschin Gandjour

Reply to comment on “Demonstrating the value of cancer biomarkers at the population” pp. 757-758

Ana Beatriz D’Avó Luís and Mikyung Kelly Seo

Volume 23, issue 3, 2022

Public health policies for the common interest: rethinking EU states’ incentives strategies when a pandemic reshuffles all interests pp. 329-335

Juan Llano, Jorge Mestre-Ferrandiz, Jaime Espin, Jordi Gol-Montserrat, Alicia Llano and Carlos Bringas

Online and offline health information seeking and the demand for physician services pp. 337-356

Hiroaki Suenaga and Maria Rosalía Vicente

Valuing informal carers’ quality of life using best-worst scaling—Finnish preference weights for the Adult Social Care Outcomes Toolkit for carers (ASCOT-Carer) pp. 357-374

Lien Nguyen, Hanna Jokimäki, Ismo Linnosmaa, Eirini-Christina Saloniki, Laurie Batchelder, Juliette Malley, Hui Lu, Peter Burge, Birgit Trukeschitz and Julien Forder

Cost-effectiveness evidence on approved cancer drugs in Ireland: the limits of data availability and implications for public accountability pp. 375-431

Suaad Almajed, Nora Alotaibi, Sana Zulfiqar, Zahraa Dhuhaibawi, Niall O’Rourke, Richard Gaule, Caoimhe Byrne, Aaron M. Barry, Dylan Keeley and James F. O’Mahony

A guide to extending and implementing generalized risk-adjusted cost-effectiveness (GRACE) pp. 433-451

Darius Lakdawalla and Charles E. Phelps

Does the amount of formal care affect informal care? Evidence among over-60s in France pp. 453-465

Elsa Perdrix and Quitterie Roquebert

Income and conversion handicaps: estimating the impact of child chronic illness/disability on family income and the extra cost of child chronic illness/child disability in Ireland using a standard of living approach pp. 467-483

Áine Roddy

The employment situation of people living with HIV: a closer look at the effects of the 2008 economic crisis pp. 485-497

Beatriz Rodríguez-Sánchez, Luz María Peña-Longobardo and Juan Oliva

The impact of inpatient bed capacity on length of stay pp. 499-510

Brendan Walsh, Samantha Smith, Maev-Ann Wren, James Eighan and Sean Lyons

Retirement, social support and mental well-being: a couple-level analysis pp. 511-535

Nathan Kettlewell and Jack Lam

Cost-effectiveness analysis of vaborem for the treatment of carbapenem-resistant Enterobacteriaceae-Klebsiella pneumoniae carbapenemase (CRE-KPC) infections in the UK pp. 537-549

Ioanna Vlachaki, Daniela Zinzi, Edel Falla, Theo Mantopoulos, Holly Guy, Jasimran Jandu and Andrew Dodgson

Cost-minimization analysis of immunoglobulin treatment of primary immunodeficiency diseases in Spain pp. 551-558

Laia Alsina, J. Bruno Montoro, Pedro Moral Moral, Olaf Neth, Marta Ortiz Pica, Silvia Sánchez-Ramón, María Presa, Itziar Oyagüez, Miguel Ángel Casado and Luis Ignacio González-Granado

Volume 23, issue 2, 2022

Value-based pricing for advanced therapy medicinal products: emerging affordability solutions pp. 155-163

Elisabete Gonçalves

Measuring health-related quality of life and well-being: a head-to-head psychometric comparison of the EQ-5D-5L, ReQoL-UI and ICECAP-A pp. 165-176

Richard Huan Xu, Anju Devianee Keetharuth, Ling-ling Wang, Annie Wai-ling Cheung and Eliza Lai-yi Wong

The economic burden of obesity in Italy: a cost-of-illness study pp. 177-192

Margherita d’Errico, Milena Pavlova and Federico Spandonaro

Economic evaluation of a complex intervention (Engager) for prisoners with common mental health problems, near to and after release: a cost-utility and cost-consequences analysis pp. 193-210

Rachael Maree Hunter, Rob Anderson, Tim Kirkpatrick, Charlotte Lennox, Fiona Warren, Rod S. Taylor, Jenny Shaw, Mark Haddad, Alex Stirzaker, Mike Maguire and Richard Byng

Machine learning versus regression modelling in predicting individual healthcare costs from a representative sample of the nationwide claims database in France pp. 211-223

Alexandre Vimont, Henri Leleu and Isabelle Durand-Zaleski

Mapping of head and neck cancer patient concerns inventory scores on to Euroqol-Five Dimensions-Five Levels (EQ-5D-5L) health utility scores pp. 225-235

Krishnakumar Thankappan, Tejal Patel, Krishna Kollamparambil Ajithkumar, Deepak Balasubramanian, Manu Raj, Sujha Subramanian and Subramania Iyer

Simulating lifestyle and medical interventions to prevent type-2 diabetes: an economic evaluation for Belgium pp. 237-248

Désirée Vandenberghe

The cost of lost productivity due to premature mortality associated with COVID-19: a Pan-European study pp. 249-259

Paul Hanly, Michelle Ahern, Linda Sharp, Diana Ursul and Gerard Loughnane

Is prevention of suicide worth less? A comparison of the value per statistical life pp. 261-275

Vimefall Elin, Persson Mattias, Olofsson Sara and Lars Hultkrantz

Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression pp. 277-299

Christian R. C. Kouakou and Thomas G. Poder

The contribution of resident physicians to hospital productivity pp. 301-312

Maria J. Perez-Villadóniga, Ana Rodriguez-Alvarez and David Roibas

Estimating the additional costs of living with a disability in the United Kingdom between 2013 and 2016 pp. 313-327

Lukas Schuelke, Luke Munford and Marcello Morciano

Volume 23, issue 1, 2022

The Italian NHS at regional level: same in theory, different in practice pp. 1-5

Livio Garattini, Marco Badinella Martini and Michele Zanetti

Effects of establishing a financing scheme for outpatient care on inpatient services: empirical evidence from a quasi-experiment in China pp. 7-22

Wen He

Costs and management of patients with hemophilia A in France: the Hemraude study pp. 23-32

C. Laurendeau, J. Goudemand, M. Trossaert, B. Polack, R. Varin, C. Godard, F. Hadim and B. Detournay

Production losses due to mortality associated with modifiable health risk factors in Poland pp. 33-45

Błażej Łyszczarz and Karolina Sowa

HIT-6 and EQ-5D-5L in patients with migraine: assessment of common latent constructs and development of a mapping algorithm pp. 47-57

Ana Sofia Oliveira Gonçalves, Dimitra Panteli, Lars Neeb, Tobias Kurth and Annette Aigner

Effects of provider incentives on dental X-raying in NHS Scotland: what happens if patients switch providers? pp. 59-65

Olivier Kalmus, Martin Chalkley and Stefan Listl

The effect of influenza and pneumococcal vaccination in the elderly on health service utilisation and costs: a claims data-based cohort study pp. 67-80

Josephine Storch, Carolin Fleischmann-Struzek, Norman Rose, Thomas Lehmann, Anna Mikolajetz, Srikanth Maddela, Mathias W. Pletz, Christina Forstner, Ole Wichmann, Julia Neufeind, Monique Vogel, Konrad Reinhart, Horst Christian Vollmar and Antje Freytag

Did the COVID-19 pandemic change the willingness to pay for an early warning system for infectious diseases in Europe? pp. 81-94

Sebastian Himmler, Job Exel and Werner Brouwer

The impact of cancellations in waiting times analysis: evidence from scheduled surgeries in the Portuguese NHS pp. 95-104

Joana Cima and Álvaro Almeida

Timing of non-pharmaceutical interventions to mitigate COVID-19 transmission and their effects on mobility: a cross-country analysis pp. 105-117

Amit Summan and Arindam Nandi

Health effects from heat waves in France: an economic evaluation pp. 119-131

Lucie Adélaïde, Olivier Chanel and Mathilde Pascal

Use of past care markers in risk-adjustment: accounting for systematic differences across providers pp. 133-151

Laura Anselmi, Yiu-Shing Lau, Matt Sutton, Anna Everton, Rob Shaw and Stephen Lorrimer

Correction to: The cost of lost productivity due to premature mortality associated with COVID-19: a Pan-European study pp. 153-153

Paul Hanly, Michelle Ahern, Linda Sharp, Diana Ursul and Gerard Loughnane